Kaya Limited has formally announced a Board of Directors meeting scheduled for January 28, 2026, to review the company's third-quarter financial performance for FY26. The healthcare company submitted the notification to both BSE and NSE exchanges as part of its regulatory compliance obligations.

Board Meeting Details

The board meeting has been organized to address several key agenda items related to the company's quarterly financial disclosure requirements.

Regulatory Compliance and Trading Window

In accordance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 29, Kaya Limited has implemented necessary trading restrictions during the financial results preparation period.

Exchange Communication

The company has formally communicated the board meeting schedule to both major Indian stock exchanges where its shares are listed. The notification was signed by Company Secretary and Compliance Officer Nitika Dalmia on January 16, 2026.

The meeting represents a standard quarterly review process where the board will evaluate the company's financial performance for the third quarter of fiscal year 2026. The results will include both standalone and consolidated financial statements, providing comprehensive insights into the company's operational and financial status during the October-December 2025 period.

Expected Outcomes

Following the board meeting on January 28, 2026, Kaya Limited is expected to release its official Q3FY26 financial results to the public and regulatory authorities. The trading window closure ensures compliance with insider trading regulations during the sensitive period of financial results preparation and board deliberation.

Kaya Limited has announced a key senior management appointment, bringing aboard an experienced business leader to drive transformation initiatives. The healthcare company has strengthened its leadership team with the addition of a seasoned professional with extensive experience across multiple high-growth sectors.

Leadership Appointment Details

Kaya Limited has appointed Saurav Jha as Chief Business Transformation Officer effective December 22, 2025. The appointment was approved by the Board of Directors through a Circular Resolution dated December 17, 2025, marking a strategic addition to the company's senior management personnel.

Professional Background and Experience

Saurav Jha brings over 18 years of comprehensive experience across multiple business domains including business operations, category management, market expansion, retail and analytics. His career spans leadership roles in high-growth, technology-driven companies, positioning him well for the transformation role at Kaya Limited.

Jha's most recent position was at CaratLane. Prior to this, he worked with Urban Company, contributing to his diverse experience in technology-driven environments.

Career Highlights

Throughout his career, Jha has held leadership positions across several prominent organizations:

• CaratLane: Senior role
• Urban Company: Leadership role in business operations
• Other experiences in technology, analytics, and business services

Strategic Implications

The appointment of Jha as Chief Business Transformation Officer reflects Kaya Limited's focus on business evolution and growth strategies. His extensive experience in companies like CaratLane and Urban Company aligns with the transformation objectives of the healthcare services provider. The appointment, effective December 22, 2025, positions the company to leverage his expertise in driving strategic initiatives in the coming period.